PSTV

#4463
PLUS THERAPEUTICS, Inc. Common Stock
5.39 USD
-0.74%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
5.39
5.50
Faixa anual
0.13
6.02
Mudança diária
-0.74%
Mudança mensal
+1896.30%
Mudança em 6 meses
+704.48%
Mudança anual
+783.61%
Fechamento anterior
5.43
Abrir
5.44
Bid
Ask
Mínimo
5.39
High
5.50
Volume
16
Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
Demonstração de resultados Balanço patrimonial Fluxo de caixa
Valor Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM

PLUS THERAPEUTICS Inc

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecular diagnostic service, CNSide®.

Notícias